Gentile Kimberly 4
4 · Biohaven Ltd. · Filed Nov 6, 2023
Insider Transaction Report
Form 4
Biohaven Ltd.BHVN
Gentile Kimberly
SVP, Clinical Operations
Transactions
- Award
Stock Options (Right to buy)
2023-11-02+78,750→ 78,750 totalExercise: $29.49Exp: 2033-11-02→ Common Shares (78,750 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in four equal installments on November 2, 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service with the Issuer at each vesting date.